Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis

Eva Baecklund; Yasodha Natkunam; Carin Backlin; Anastasia Iliadou; Johan Askling; Anders Ekbom; Nils Feltelius; Lars Klareskog; Gunilla Enblad; Izidore Lossos; Ronald Levy; Christer Sundström; Richard Rosenquist

doi:10.1111/j.1365-2141.2008.07011.x

Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis

Eva Baecklund, Yasodha Natkunam, Carin Backlin, Anastasia Iliadou, Johan Askling, Anders Ekbom, Nils Feltelius, Lars Klareskog, Gunilla Enblad, Izidore Lossos, Ronald Levy, Christer Sundström, Richard Rosenquist

Medicine

Research output: Contribution to journal › Article

15 Scopus citations

Abstract

Diffuse large B-cell lymphomas (DLBCL) can be subdivided into germinal centre (GC)-like and non-GC-like subtypes by CD10, BCL6 and MUM1/IRF4 status. We previously reported that patients with severe rheumatoid arthritis (RA) are at increased risk of non-GC DLBCL. This study examined a new GC-marker, human germinal-centre-associated lymphoma (HGAL) protein, in RA-DLBCL. Of 111, 38 (34%) DLBCL were HGAL-positive and showed less disseminated disease and a tendency toward improved overall survival compared to HGAL-negative cases. This supports that a majority of RA-DLBCL are of non-GC origin, indicating a specific role for activated peripheral B cells in the pathogenesis of RA-DLBCL.

Original language	English
Pages (from-to)	69-72
Number of pages	4
Journal	British Journal of Haematology
Volume	141
Issue number	1
DOIs	https://doi.org/10.1111/j.1365-2141.2008.07011.x
State	Published - Apr 1 2008

Fingerprint

Keywords

B-cells
Diffuse large B-cell lymphoma
Human germinal-centre-associated protein
Lymphoma
Rheumatoid arthritis

ASJC Scopus subject areas

Hematology

Cite this

Baecklund, E., Natkunam, Y., Backlin, C., Iliadou, A., Askling, J., Ekbom, A., Feltelius, N., Klareskog, L., Enblad, G., Lossos, I., Levy, R., Sundström, C., & Rosenquist, R. (2008). Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis. British Journal of Haematology, 141(1), 69-72. https://doi.org/10.1111/j.1365-2141.2008.07011.x

Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis. / Baecklund, Eva; Natkunam, Yasodha; Backlin, Carin; Iliadou, Anastasia; Askling, Johan; Ekbom, Anders; Feltelius, Nils; Klareskog, Lars; Enblad, Gunilla; Lossos, Izidore; Levy, Ronald; Sundström, Christer; Rosenquist, Richard.

In: British Journal of Haematology, Vol. 141, No. 1, 01.04.2008, p. 69-72.

Research output: Contribution to journal › Article

Baecklund, E, Natkunam, Y, Backlin, C, Iliadou, A, Askling, J, Ekbom, A, Feltelius, N, Klareskog, L, Enblad, G, Lossos, I, Levy, R, Sundström, C & Rosenquist, R 2008, 'Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis', British Journal of Haematology, vol. 141, no. 1, pp. 69-72. https://doi.org/10.1111/j.1365-2141.2008.07011.x

Baecklund, Eva ; Natkunam, Yasodha ; Backlin, Carin ; Iliadou, Anastasia ; Askling, Johan ; Ekbom, Anders ; Feltelius, Nils ; Klareskog, Lars ; Enblad, Gunilla ; Lossos, Izidore ; Levy, Ronald ; Sundström, Christer ; Rosenquist, Richard. / Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis. In: British Journal of Haematology. 2008 ; Vol. 141, No. 1. pp. 69-72.

@article{33801a350470414081957b78b30a5223,

title = "Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis",

abstract = "Diffuse large B-cell lymphomas (DLBCL) can be subdivided into germinal centre (GC)-like and non-GC-like subtypes by CD10, BCL6 and MUM1/IRF4 status. We previously reported that patients with severe rheumatoid arthritis (RA) are at increased risk of non-GC DLBCL. This study examined a new GC-marker, human germinal-centre-associated lymphoma (HGAL) protein, in RA-DLBCL. Of 111, 38 (34%) DLBCL were HGAL-positive and showed less disseminated disease and a tendency toward improved overall survival compared to HGAL-negative cases. This supports that a majority of RA-DLBCL are of non-GC origin, indicating a specific role for activated peripheral B cells in the pathogenesis of RA-DLBCL.",

keywords = "B-cells, Diffuse large B-cell lymphoma, Human germinal-centre-associated protein, Lymphoma, Rheumatoid arthritis",

author = "Eva Baecklund and Yasodha Natkunam and Carin Backlin and Anastasia Iliadou and Johan Askling and Anders Ekbom and Nils Feltelius and Lars Klareskog and Gunilla Enblad and Izidore Lossos and Ronald Levy and Christer Sundstr{\"o}m and Richard Rosenquist",

year = "2008",

month = apr

day = "1",

doi = "10.1111/j.1365-2141.2008.07011.x",

language = "English",

volume = "141",

pages = "69--72",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis

AU - Baecklund, Eva

AU - Natkunam, Yasodha

AU - Backlin, Carin

AU - Iliadou, Anastasia

AU - Askling, Johan

AU - Ekbom, Anders

AU - Feltelius, Nils

AU - Klareskog, Lars

AU - Enblad, Gunilla

AU - Lossos, Izidore

AU - Levy, Ronald

AU - Sundström, Christer

AU - Rosenquist, Richard

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Diffuse large B-cell lymphomas (DLBCL) can be subdivided into germinal centre (GC)-like and non-GC-like subtypes by CD10, BCL6 and MUM1/IRF4 status. We previously reported that patients with severe rheumatoid arthritis (RA) are at increased risk of non-GC DLBCL. This study examined a new GC-marker, human germinal-centre-associated lymphoma (HGAL) protein, in RA-DLBCL. Of 111, 38 (34%) DLBCL were HGAL-positive and showed less disseminated disease and a tendency toward improved overall survival compared to HGAL-negative cases. This supports that a majority of RA-DLBCL are of non-GC origin, indicating a specific role for activated peripheral B cells in the pathogenesis of RA-DLBCL.

AB - Diffuse large B-cell lymphomas (DLBCL) can be subdivided into germinal centre (GC)-like and non-GC-like subtypes by CD10, BCL6 and MUM1/IRF4 status. We previously reported that patients with severe rheumatoid arthritis (RA) are at increased risk of non-GC DLBCL. This study examined a new GC-marker, human germinal-centre-associated lymphoma (HGAL) protein, in RA-DLBCL. Of 111, 38 (34%) DLBCL were HGAL-positive and showed less disseminated disease and a tendency toward improved overall survival compared to HGAL-negative cases. This supports that a majority of RA-DLBCL are of non-GC origin, indicating a specific role for activated peripheral B cells in the pathogenesis of RA-DLBCL.

KW - B-cells

KW - Diffuse large B-cell lymphoma

KW - Human germinal-centre-associated protein

KW - Lymphoma

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=40449110250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40449110250&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2008.07011.x

DO - 10.1111/j.1365-2141.2008.07011.x

M3 - Article

C2 - 18324968

AN - SCOPUS:40449110250

VL - 141

SP - 69

EP - 72

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 1

ER -

Access to Document

10.1111/j.1365-2141.2008.07011.x